Diltiazem treatment does not alter renal function after thoracic surgery Journal Article


Authors: Amar, D.; Fleisher, M.
Article Title: Diltiazem treatment does not alter renal function after thoracic surgery
Abstract: Background: There are conflicting reports on the effects of diltiazem treatment on renal function in surgical patients. We sought to determine whether diltiazem treatment alters renal function in patients undergoing major thoracic surgery. Methods: In a prospective study, 330 patients scheduled for elective thoracic surgery received either IV diltiazem (n = 167) or placebo (n = 163) immediately after the operation and orally thereafter for 14 days in an effort to prevent postoperative atrial arrhythmias. Serum creatinine and BUN levels were compared before and during the first postoperative week. Results: Patients treated with diltiazem were similar to control subjects in terms of age (mean ± SD, 66 ± 10 years vs 67 ± 10 years, respectively), baseline serum creatinine or BUN levels, prevalence of comorbid conditions, and surgical characteristics. During the first 5 postoperative days, the two groups did not differ in terms of serum creatinine or BUN levels. The incidence of renal failure was 0.6% in the diltiazem group and 1.2% in the placebo group (difference was not significant). There was no difference in the length of hospitalization or mortality rate. Conclusions: In patients without renal disease who are undergoing elective thoracic surgery, prophylactic diltiazem treatment did not alter postoperative renal function.
Keywords: controlled study; aged; major clinical study; clinical trial; mortality; placebo; comparative study; postoperative care; prospective studies; controlled clinical trial; randomized controlled trial; pneumonectomy; incidence; creatinine blood level; kidney failure; drug effect; age; postoperative complications; length of stay; kidney function; comorbidity; surgery; double blind procedure; thorax surgery; heart atrium arrhythmia; diltiazem; renal function; kidney diseases; urea blood level; cardiovascular agents; humans; human; male; female; priority journal; article
Journal Title: Chest
Volume: 119
Issue: 5
ISSN: 0012-3692
Publisher: American College of Chest Physicians  
Date Published: 2001-05-01
Start Page: 1476
End Page: 1479
Language: English
DOI: 10.1378/chest.119.5.1476
PUBMED: 11348956
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 21 May 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David Amar
    137 Amar
  2. Martin Fleisher
    312 Fleisher